Skip to main content

Table 3 Target coverage comparison

From: Dosimetric advantage of volumetric modulated arc therapy in the treatment of intraocular cancer

PTV

CRT

IMRT

VMAT

P-value

CRT vs IMRT

CRT vs VMAT

IMRT vs VMAT

Dmean(cGy)

5065.87 ± 111.52

5175.76 ± 38.45

5157.21 ± 52.23

<0.01

0.04

0.20

V95 (%)

95.02 ± 0.67

95.51 ± 2.25

95.92 ± 3.05

0.48

0.91

0.30

D95(cGy)

4750.5 ± 14.25

4789 ± 150.20

4756.86 ± 132.03

0.37

0.86

0.32

D1(cGy)

5303.43 ± 175.25

5422.32 ± 35.59

5425.00 ± 33.59

0.02

0.03

0.84

D99(cGy)

4540.50 ± 109.96

4274.62 ± 277.51

4268.57 ± 304.07

<0.01

0.01

0.92

HI

0.15 ± 0.05

0.23 ± 0.05

0.23 ± 0.06

<0.01

<0.01

0.89

CI

0.94 ± 0.01

0.95 ± 0.02

0.95 ± 0.03

0.23

0.87

0.29

EUD(cGy)

4791.42 ± 834.88

4896.8 ± 408.80

4824.45 ± 423.00

0.47

0.881

0.52

TCP

0.90 ± 0.25

0.94 ± 0.10

0.95 ± 0.09

0.39

0.67

0.88